Florida Patent of the Month – March 2024
Bazelet Health Systems, Inc. has unveiled a groundbreaking invention in the realm of cannabinoid research that aims to revolutionize therapeutic approaches. Their latest invention, a novel capsule formulation, encapsulates the power of cannabigerol (CBG) alongside palmitoylethanolamide (PEA), piperine, and curcumin, presenting a unique synergy for enhanced oral absorption and efficacy.
Bazelet Health Systems was inspired by the broad range of uses afforded by cannabis. They view this plant as one of the most valuable on earth thanks to its potential to transform food, medicine, beauty, genetics, health and so on. Their recently patented composition, marketed as Cannabis-ZERO™ provides the world with access to legal, non-psychoactive cannabis products.
At the heart of this innovation lies the potent combination of CBG, a cannabinoid known for its diverse pharmacological properties, and PEA, a fatty acid amide with anti-inflammatory and neuroprotective effects. By harnessing the potential of these two compounds, Bazelet Health Systems aims to unlock new avenues for addressing various health conditions.
The inclusion of piperine and curcumin further amplifies the therapeutic impact of the capsule. Piperine, derived from black pepper, is renowned for its ability to enhance the bioavailability of nutrients and pharmaceuticals. Curcumin, extracted from turmeric, boasts anti-inflammatory, antioxidant, and neuroprotective properties, complementing the holistic approach of the formulation.
This innovative capsule represents a significant milestone in cannabinoid research, offering a safe, effective, and versatile solution for a wide range of health issues. With its carefully curated blend of natural ingredients, it holds promise for conditions such as chronic pain, inflammation, neurological disorders, and more.
Moreover, the absence of tetrahydrocannabinol (THC) and cannabidiol (CBD) in the formulation ensures a non-psychoactive experience, making it suitable for individuals seeking therapeutic benefits without unwanted side effects.
Bazelet Health Systems’ dedication to research and development is evident in this novel invention. By pushing the boundaries of cannabinoid science, they strive to empower individuals worldwide with innovative solutions for better health and well-being.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
Are you eligible?
Why choose us?
Pass an Audit?
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
Never miss a deadline again
Stay up to date on IRS processes
Discover R&D in your industry
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state
